Clemens, M J <br/><br/>
Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines.  [electronic resource] 

 -  Oncogene  Dec 1998 
 - 2921-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1202227  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Chloromethyl Ketones--pharmacology<br/>Antibodies--pharmacology<br/>Apoptosis--drug effects<br/>Caspase Inhibitors<br/>Caspases--metabolism<br/>Culture Media, Serum-Free<br/>Cycloheximide--pharmacology<br/>Etoposide--pharmacology<br/>Eukaryotic Initiation Factor-4E<br/>Half-Life<br/>Humans<br/>Jurkat Cells<br/>Lymphoma--enzymology<br/>Molecular Weight<br/>Neoplasm Proteins--biosynthesis<br/>Oligopeptides--pharmacology<br/>Peptide Initiation Factors--isolation & purification<br/>Poly(A)-Binding Proteins<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Protein Synthesis Inhibitors--pharmacology<br/>RNA-Binding Proteins--metabolism<br/>Sirolimus--pharmacology<br/>Tumor Cells, Cultured<br/>fas Receptor--immunology